The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Interested in McKesson Corporation? Here are five stocks we like better.
McKesson plans to acquire Precision Medicine Group for $2.25 billion, expanding its oncology and biopharma-services businesses with clinical-trial, CRO, payer-strategy and market-access capabilities.
First-quarter results were strong: North American Pharmaceutical Distribution revenue rose about 5% with adjusted operating profit up 19%, while Oncology and Multi-Specialty revenue and profit increased approximately 33% and 41%, respectively.
McKesson expects to return roughly $5 billion to shareholders this year, including $2.5 billion in first-quarter buybacks and a 15% dividend increase, while continuing investments in automation, artificial intelligence and growth initiatives.